Comparative polymerase chain reaction analysis of c-myc amplification on archival breast fine-needle aspiration materials

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 2, 2000, Pages 175-179

  Rao, JianYu ^a   Apple, Sophia K ^a,b   Jin, YuShen ^a   Lin, Suhua ^a   Nieberg, Roberta K ^a   Hirtschowitz, Sharon L ^a  

^a UCLA MEDICAL CENTER   (United States)

^b WOODLAND HILLS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DNA; MYC PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BREAST CANCER; BREAST FIBROADENOMA; CANCER RISK; CELL STRAIN HL 60; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; FIBROCYSTIC BREAST DISEASE; FLUORESCENCE; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE C MYC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGED; APOPTOSIS; BIOPSY, NEEDLE; BREAST; BREAST NEOPLASMS; CELL DIVISION; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TUMOR MARKERS, BIOLOGICAL;

EID: 0033999730     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Demay, R. M. B. Rao, P. Rogers, and J. Schima (eds.), In: Breast, The art and science of cytopathology. Vol. 2, Aspiration Cytology. Chicago, IL: American Society of Clinical Pathologists Press, 1996.
2. Dhingra, K., Vogel, V., Sneige, N., Sahin, A., Aldaz, M., Hortobagyi, G. N., and Hittelman, W. Strategies for the application of biomarkers for risk assessment and efficacy in breast cancer chemoprevention trials. J. Cell. Biochem., I7G: 37-43, 1993.
3. Rao, J. Y., Apple, S., Jin, Y. S., Hemstreet, G. P., and Nieberg, R. Single cell multiple biomarker analysis in archival fine-needle aspiration specimens: quantitative fluorescence image analysis of DNA ploidy, p53, and G-actin as breast cancer biomarkers. Cancer Epidemiol. Biomark. Prev., 7: 1027-1033, 1998.
4. Kreipe, H., Feist, H., Fischer, L., Feigner, J., Heidorn, K., Mettler, L., Parwaresch, R. Amplification of c-myc but not of c-erbB-2 is associated with high proliferative capacity in breast cancer. Cancer Res., 53: 1956-1961, 1993.
5. Watson, P. H., Safneck, J. R., Le, K., Dubik, D., and Shiu, R. P. Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis. J. Natl. Cancer Inst., 85: 902-907, 1993.
6. Escot, C., Simony-Lafontaine, J., Maudelonde, T., Puech, C., Pujol, H., and Rochefort, H. Potential value of increased c-myc but not ERB2 RNA levels as a marker of high risk mastopathies. Oncogene. 8: 969-974, 1993.
7. Salami, N., Hirschowitz, S. L., Nieberg, R., and Apple, S. K. Triple test approach to inadequate fine needle aspiration biopsies of palpable breast lesions. Acta Cytol., 43: 339-343, 1999.
8. De Melo, M. B., Sales, T. S. I., Lorand-Metze, I., and Costa, F. F. Rapid method for isolation of DNA from glass slide smears for PCR. Acta Hematol., 87: 214-215, 1992.
9. Ribot, E. M., Quinn, F. D., Bai, X., and Murtagh, J. J. Comparative PCR: an improved method to detect gene amplification. Biotechniques, 24: 22-26, 1998.
10. Hemstreet, G. P., Rao, J. Y., Hurst, R. E., Bonner, R. B., Jones, P. L., Vaidya, A. M., Fradet, Y., Moon, R. C., and Kelloff, G. J. Intermediate endpoint marker for chemoprevention. J. Cell. Biochem., 161 (Suppl.): 93-110, 1992.
11. Schatzkin, A., Freedman, L. S., Schiffman, M. H., and Dawsey, S. M. Validation of intermediate end points in cancer research. J. Natl. Cancer Inst. 82: 1746-1752, 1990.
12. Dhingra, K., Vogel, V., Sneige, N., Sahin, A., Aldaz, M., Hortobagyi, G. N., and Hittelman, W. Strategies for the applications of biomarkers for risk assessment and efficacy in breast cancer chemoprevention trials. J. Cell. Biochem., 17G: 37-43, 1993.